Last reviewed · How we verify
Transabdominal Plane Block
At a glance
| Generic name | Transabdominal Plane Block |
|---|---|
| Also known as | Bupivacaine |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair (NA)
- Intrathecal MoRphine Versus Transabdominal Plane Block (TAP) Block for AnalGesic Management in Elective Caesarean Section (PHASE4)
- Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain Control (PHASE4)
- Post-Cesarean Gastrointestinal Dysfunction
- Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs (PHASE2, PHASE3)
- TAP Block , Intrathecal Morphine Or Their Combination For Post Operative Analgesia Following TAH (PHASE1)
- Effect of Transversus Abdominis Plane Block on Diaphragm Thickness (NA)
- The Effect of Preemptive Regional Anesthesia (TAP-block) on Acute and Chronic Pain After Transabdominal Preperitoneal Inguinal Hernia Repair (TAPP) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Transabdominal Plane Block CI brief — competitive landscape report
- Transabdominal Plane Block updates RSS · CI watch RSS
- Icahn School of Medicine at Mount Sinai portfolio CI